No change in uPA, CD44 and MDR1 expression was observed during the metastatic process, whereas others have observed a downregulation of CD44 during tumour progression in mice (Yeo et al, 1996) and in human ascitic tumour cells (Ross et al, 2001). Here, CD44 is linked to neoplasm.